Volume 8, Issue 30 (3-2000)                   J Adv Med Biomed Res 2000, 8(30): 75-84 | Back to browse issues page

XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousavi Kazemi S H, Motabar M. Evaluation Of Residual Effect Of Cyfluthrin (Solfac Wp 10%) For Malaria Control In Hormozgan Province, South Of Iran. J Adv Med Biomed Res 2000; 8 (30) :75-84
URL: http://journal.zums.ac.ir/article-1-494-en.html
Abstract:   (149177 Views)
An Interventional and field trial study was carried out the siaho and shamell area, (Bandar Abbas, South of Iran) during 1996 - 1997 . In this survey efficacy of cytluthin was compared to that of untreated and treated villages, in relation malaria control 10 and 11 villages with a total population of 3236 , 8272 and 3 , 3 villages with a total population of 1267 , 3675 were used as treatment and control in siaho and shamell areas, respectively.The residual spraging with target dosage of 50 mg active ingredient [AI]/ M2 , carried out in early April, were done by Local Health workers.The use of cytluthrin Insecticide has significant effect on the parous rate, indoor resting density, human and animal blood behavior of vectors, Incidence of malaria and positive slide.In night catch maximum of Anopheline collection at 23 and 21 respectively. Bioassay contact mortality test with cytluthrin at a rate of 50 ai, mg. m2 on wood, mud. pluster, cement surfaces dropped from 100% to 97.1 , 96.1 , 96.6, after 150, 120 , 150 , 80 and from 100% to 98.2, 97 95.1, 97.1 after 151 , 122 , 122 , 98 days of hut spraying in siaho and shamell respectivety.Fumigunt mortality test dropped from 100% after 36 and 33 days in shamell and siaho respectively. In south of Iran with different Vectors, exophilic and endophagic habit, long transmission, the use of residual spraying with cyfluthrin with target dosage of 50 mg.ai. m2 could be used.
Full-Text [PDF 1367 kb]   (156488 Downloads)    
Type of Study: Original Research Article |
Received: 2008/11/12 | Accepted: 2000/03/15 | Published: 2000/03/15

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Journal of Advances in Medical and Biomedical Research

Designed & Developed by : Yektaweb